Search
Browse
Statistics
Feeds

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
617kB

Item Type:Article
Title:Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry
Creators: Carnero Contentti, E. ORCID logoORCID: https://orcid.org/0000-0001-7435-5726, Lopez, P.A. ORCID logoORCID: https://orcid.org/0000-0002-7705-095X, Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Cristiano, E., Patrucco, L., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M. ORCID logoORCID: https://orcid.org/0000-0002-4142-8375, Ysrraelit, M.C., Leguizamon, F., Luetic, G. ORCID logoORCID: https://orcid.org/0000-0002-5716-6082, Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R. ORCID logoORCID: https://orcid.org/0000-0001-9955-8343, Fernández Liguori, N., Nadur, D., Alonso Serena, M., Caride, A., Paul, F. ORCID logoORCID: https://orcid.org/0000-0002-6378-0070 and Rojas, J.I.
Abstract:We aimed to evaluate mortality and causes of death among Argentinean neuromyelitis optica spectrum disorder (NMOSD) patients and identify predictors of death. Retrospective study included 158 NMOSD patients and 11 (7%) patients died after 11 years of follow-up for a total exposure time of 53,345 days with an overall incidence density of 2.06 × 10.000 patients/day (95% CI 1.75-2.68). Extensive cervical myelitis with respiratory failure (45%) was the most frequent cause of death. Older age (HR = 2.05, p = 0.002) and higher disability score (HR = 2.30, p < 0.001) at disease onset were independent predictors of death. We found an 11-year mortality rate of 7% in Argentinean NMOSD patients.
Keywords:Neuromyelitis Optica (NMO), Mortality, Latin America, Prognosis, Relapses
Source:Multiple Sclerosis Journal Experimental Translational and Clinical
ISSN:2055-2173
Publisher:Sage Publications
Volume:9
Number:4
Page Range:20552173231205444
Date:17 October 2023
Official Publication:https://doi.org/10.1177/20552173231205444
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library